Machine Learning

The biotech firm lands a major private placement, extending its cash runway to 2028 and signaling strong investor confidence in its novel drug platform.

Major insurers now cover advanced AI plaque analysis, paving the way for personalized heart attack prevention and a new standard of cardiovascular care.

The biotech firm now expects Phase 2 results in Q3 2026, accelerating hope for new CNS treatments and signaling strong operational momentum to investors.

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

A new platform, ConvoGPT OS, has been unveiled with a bold mission: to eliminate human sales jobs, not just assist them, raising major questions for the future of work.

From a $2.3B real estate privatization to blockbuster retail earnings and a shifting job market, key corporate moves reveal a nation at a crossroads.

Crypto exchange HTX reveals 39% growth in its 2025 report, but the real story is its strategic pivot to tech, compliance, and long-term value.

Laser tool maker Huepar validates its 5-year warranty with automated precision and plans a major service expansion in the UK, Europe, and the US.

Pudu Robotics' new PUDU T150 aims to democratize factory automation with promises of fast deployment and lower costs for small and mid-sized businesses.

As 2026 begins, the crypto market sees a split personality: a wild memecoin surge alongside a steady, tech-driven recovery in the AI sector.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

A new report reveals shifting consumer demands for THCA flower, as the booming market grapples with quality standards and a complex regulatory future.

FieldBee Vision's gold medal win at LAMMA 2026 signals a new era of accessible, AI-driven precision agriculture for farms of all sizes.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

A key regulatory shift enables US-based Monnit to partner with Widetec, aiming to solve Japan's labor and infrastructure challenges with IoT solutions.

With a massive IKEA partnership, supply chain leader Made4net proves unified omnichannel fulfillment is no longer an option, but the new standard for retail.